/Companies

Imago AI

Techstars '19

Gurgaon, IN · Founded 2019 · 7 employees on LinkedIn · 2 known investors

Find your way into Imago AI

ImagoAI develops rapid food safety and quality testing solutions using hyperspectral imaging combined with AI for the food industry. The company targets on-site testing needs, particularly for detecting mycotoxins and other contaminants in food supply chains.

Also known as Imago AI · ImagoAI

Founders & leadership

Imago AI was founded in 2019 by Shweta and Abhishek.

SShweta
ShwetaFounder
AAbhishek
AbhishekFounder

Investors · 2

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

ImagoAI is a food-technology company that applies hyperspectral imaging and machine learning to rapid, on-site testing of raw and manufactured food. Its imaging hardware captures 3-D images with more than 200 spectral bands, recording a chemical signature at every pixel; AI models trained on hyperspectral pixel data and thousands of samples then convert those scans into quantitative results. The workflow is presented as three steps — place a sample on the tray, record a scan, and analyze — and requires no consumables or wet chemistry.

The company's commercial line is branded Galaxy. The corn mycotoxin test quantifies aflatoxins, DON, fumonisins and zearalenone in ground corn in under 30 seconds for four mycotoxins. Additional advertised applications cover mycotoxins in corn and DDGS, vitamin content in premixes and breakfast cereals, and particle size in corn and premixes. ImagoAI positions Galaxy as delivering multiple tests in less than 30 seconds at roughly half the cost of conventional testing and with large reductions in labor time.

At its 2018 TechCrunch Disrupt Berlin Battlefield appearance the company was described as an Indian agtech startup using computer vision and machine learning to automate measurement of crop output and quality for seed companies — so-called high-throughput precision phenotyping — with the stated aim of shortening the six-to-eight-year seed development cycle and eventually correlating phenotypic with genotypic data to predict crop traits. The current product focus is food-safety and quality testing in processing and feed supply chains.

Business model

ImagoAI sells instrument-based food testing products (the Galaxy line) to food, feed and grain processors, positioning them as plug-and-play, consumable-free replacements for laboratory testing; the site references terms and conditions of sales and application-specific tests.

Traction

The company reports more than 50,000 tests performed, over 1,000 GB of hyperspectral data collected and more than 8,000 hours of labor time saved. Named adoption includes POET. The company has presented at the NAMA Corn Dry Milling Conference and the World Mycotoxin Forum in Belgium.

Latest developments

Recent activity highlighted by the company includes AOAC PTM certification of the Galaxy Mycotoxins Test for corn, adoption of the test by POET, and a collaboration with the USDA to develop a handheld mycotoxins test.

▸Full profile — market position, technology, go-to-market, geography, history

Market position

Positions the Galaxy corn mycotoxin test as the world's fastest, supported by AOAC Performance Tested Methods certification, and cites adoption by POET and a development collaboration with the USDA on a handheld mycotoxin test.

Non-destructive, consumable-free testing that returns quantitative results in seconds on site, versus laboratory chemistry methods; validated through AOAC PTM certification for the corn mycotoxin test.

Technology

Hyperspectral imaging combined with artificial intelligence. The imaging system merges digital imaging with spectroscopy to produce 3-D images with 200+ spectral bands and a chemical signature at each pixel. Analysis is performed by hundreds of micro models built on millions of hyperspectral pixels and validated on thousands of samples, producing quantitative, non-destructive results without consumables. Earlier work applied computer vision and machine learning to automated measurement of crop phenotypic traits and disease severity.

Go-to-market

Food and feed manufacturers, grain processors and ethanol/DDGS producers requiring on-site mycotoxin, vitamin and particle-size testing; earlier positioning targeted seed companies and plant-breeding programs.

Geography

Headquartered in Gurgaon, Haryana, India, with listed locations in Milpitas, California and Minneapolis and St Paul, Minnesota in the United States.

History

Founded in 2019, the company was co-founded by Shweta Gupta and Abhishek Goyal and initially applied computer vision to crop phenotyping for seed companies, presenting at TechCrunch Disrupt Berlin Startup Battlefield in November 2018, where it was a runner-up. It went through the Techstars Farm to Fork Accelerator and the Google for Startups Accelerator Women Founders class of 2021, and later focused on hyperspectral food safety and quality testing products.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Employee countJan 20241-10
HeadcountAug 20267
Hyperspectral data collectedJan 20251,000 GB
Labor hours savedJan 20258,000 hours
Mycotoxin test time (corn, 4 mycotoxins)Jan 2025under 30 seconds
Reduction in crop trait measurement time (claimed)Nov 201875%
Spectral bands captured by hyperspectral imagingJan 2025200 bands
Tests completedJan 202550,000 tests

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 6

launches, deals, and filings
Jan 2024
Collaboration with USDA to develop a handheld mycotoxins test

ImagoAI announced a collaboration with the USDA to develop a handheld mycotoxins test, covered across multiple trade press items listed on the company's media page.

source ↗

Jan 2024
POET adopts ImagoAI's Galaxy Mycotoxins Test

Ethanol producer POET adopted ImagoAI's Galaxy Mycotoxins Test, adding a new mycotoxin testing option, according to press coverage listed by the company.

source ↗

Jan 2024
Galaxy Mycotoxins Test for Corn receives AOAC Performance Tested Methods certification

ImagoAI's Galaxy Mycotoxins Test for corn achieved AOAC PTM certification and is promoted by the company as the world's fastest such test.

source ↗

Jan 2021
Selected for Google for Startups Accelerator: Women Founders Class of 2021

ImagoAI was included in the Google for Startups Accelerator Women Founders class of 2021, per press coverage listed on the company's media page.

source ↗

Jan 2019
Participation in Techstars Farm to Fork Accelerator

ImagoAI was featured in coverage of the Techstars Farm to Fork Accelerator class and is profiled on the Techstars job board.

source ↗

Nov 2018
Runner-up at TechCrunch Disrupt Berlin Startup Battlefield

Imago AI presented onstage at the 2018 TechCrunch Disrupt Berlin Startup Battlefield and finished as runner-up in the finals.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Imago AI do?
ImagoAI builds on-site food testing systems that combine hyperspectral imaging and AI to quantify mycotoxins and other quality parameters.
Who founded Imago AI?
Imago AI was founded by Shweta, Abhishek in 2019.
Who are Imago AI's investors?
Imago AI's investors include FalconX Ventures, Techstars.
Where is Imago AI headquartered?
Imago AI is headquartered in Gurgaon, IN.